Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Long Term Provisions

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Long Term Provisions History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Long Term Provisions ₹155 Cr₹123 Cr₹98 Cr₹80 Cr₹72 Cr

What is the latest Long Term Provisions ratio of MANKIND PHARMA ?

The latest Long Term Provisions ratio of MANKIND PHARMA is ₹155 Cr based on Mar2025 Consolidated results.
Year Long Term Provisions
Mar2025₹155 Cr
Mar2024₹123 Cr
Mar2023₹98 Cr
Mar2022₹80 Cr
Mar2021₹72 Cr

How is Long Term Provisions of MANKIND PHARMA Trending?

Years Long Term Provisions % Change
Mar2025 ₹155 Cr
25.94
Mar2024 ₹123 Cr
25.78
Mar2023 ₹98 Cr
22.36
Mar2022 ₹80 Cr
10.74
Mar2021 ₹72 Cr -

Compare Long Term Provisions of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹92,050.3 Cr -0.6% -8.8% -11.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,764.0 Cr 2% 6.1% 4.7% Stock Analytics
DIVIS LABORATORIES ₹170,489.0 Cr 0.1% -3.5% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,442.0 Cr -0.3% 3.8% 15.5% Stock Analytics
CIPLA ₹123,088.0 Cr 1.1% -1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,162.0 Cr 2% 4.8% 4.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.6%

-8.8%

-11.9%

SENSEX

0.9%

0.8%

7.1%


You may also like the below Video Courses